Grace Therapeutics
GRCE · NASDAQ · Health Care · Pharmaceutical Preparations
Pharmaceutical Preparations company based in Princeton, Nj.
As of Oct 20, 2026, OQRO holds for Grace Therapeutics (GRCE) over the last 12 months: 15 insider filings, 0 Congress trades, 0 fund positions and 0 federal contract awards. Most recent on file: 10% owner purchased ~$22K of GRCE shares in the open market, traded Oct 14, 2026, filed Oct 17, 2026.
Last 30 days
Written by software from the filings listed below · Oct 19, 2026
- Insiders. In the 30 days to Oct 19, 2026, insiders filed 12 open-market purchases (about $338K, in 5 filings, by 1 person) and 0 open-market sales. Grace Therapeutics on OQRO
3 more points, with the facts they come from, are in OQRO Pro.
Unlock OQRO ProExample public filing
10% owner bought ~$22K
Opaleye Management Inc., 10% owner at Grace Therapeutics, bought ~$22K of Grace Therapeutics shares.
- ~$22K
- Approx. value · 11K sh @ $1.93
- 2.88M
- Holds after · shares reported
- Traded
- Oct 14, 2026
- Filed
- Oct 17, 2026
Data as of Oct 20, 2026. A real record from the official source, chosen as the most recent insider trade or, failing that, the most recent filing of another kind; not a recommendation.
On file for GRCE, last 12 months
- 15
- Insider filings
- 0
- Congress trades
- 0
- Fund positions
- 0
- Federal contracts
Records OQRO holds, counted by their date; a 13F position is counted once per quarter it is reported.
Insider buying and selling since 2023
Insiders of Grace Therapeutics reported 17 open-market purchases and 0 sales since 2023; purchases in 2 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | 15×15 trades | — |
| 2023 | 2×2 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
See the full picture with OQRO Pro.
15 records for Grace Therapeutics in the last 12 months, each linked to its filing. Full histories, the screener, alerts for the companies you follow and Ask OQRO.
Latest disclosures
3 days free for first-time subscribers, then $9.99 a month. Nothing is charged today: your card is charged when the trial ends unless you cancel before, from your account. Secure payment by Stripe.
Public previews are free. Full research is OQRO Pro, with a 3-day free trial to start: your card is charged only when the trial ends.
Free account: get the written context of this page, built from its filings.
What this page holds
- Insider trades and planned sales
- Politician trades (House and Senate)
- Fund holdings from 13F filings
- Federal contracts, lobbying and short selling
- Full history and context, with a link to every filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Grace Therapeutics insider trading
Have Grace Therapeutics insiders bought shares recently?
Yes. Insiders of Grace Therapeutics (GRCE) filed 15 open-market purchases in the last 90 days; the latest was filed on Oct 17, 2026.
How often do Grace Therapeutics insiders buy and sell shares?
Since 2023, Grace Therapeutics insiders reported 17 open-market purchases and 0 sales on Forms 4 and 5, with purchases in 2 different years, most recently 2026.
Do members of Congress trade GRCE?
No trade in Grace Therapeutics (GRCE) was disclosed by a member of Congress in the last 12 months.
When does Grace Therapeutics report its next results?
Grace Therapeutics's next results are expected on Nov 16, 2026. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
Where does this data come from?
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.